Whitehawk Therapeutics, Inc. (WHWK) Capital expenditures 2016–2025
Whitehawk Therapeutics, Inc. (WHWK) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$552,000FY2025 · since FY2016: $113,297 → $552,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $552,000 | -66.6% |
| FY2024 | $1.7M | -58.4% |
| FY2023 | $4.0M | +794.6% |
| FY2022 | $444,000 | +865.2% |
| FY2021 | $46,000 | +141.8% |
| FY2020 | $19,025 | -92.0% |
| FY2019 | $236,952 | +525.0% |
| FY2018 | $37,912 | +326.2% |
| FY2017 | $8,896 | -92.1% |
| FY2016 | $113,297 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice